2024 Gynecologic Cancer Update: What's New in Ovarian & Gynecologic Cancers (2024)

Setting the stage for the rest of the conference, this welcome session from the Society of Gynecologic Oncology features an important research and treatment update from the current President of the SGO, Dr. Amanda Nickles Fader. 0:00 - Introduction 1:00 - Objectives 2:35 - Decade of gynecologic cancer advances 3:08 - Ovarian cancer therapies are improving 4:00 - FDA drug approvals for ovarian cancer 5:35 - 5- year survival rates are improving 6:30 - Trends for advanced ovarian cancer 7:05 - Key statistics for ovarian cancer 8:45 - Society of Gynecologic Oncology focus 12:40 - Clinical trials and BRIDGES Research Initiative 14:10 - SGO and federal funding for research 17:10 - National Cancer Institute funding 18:50 - SGO advocacy 19:30 - Chemotherapy drug shortages 22:50 - Cancers being treated without chemotherapy 24:55 - Latest ovarian cancer learnings including predictive markers, hereditary cancer syndromes 37:45 - Revolution in hereditary cancer genetic testing 41:45 - Prevention options for ovarian cancer 47:50 - Ovarian cancer mortality is on the decline